BPG is committed to discovery and dissemination of knowledge
Cited by in CrossRef
Number Cited Articles
1
Yu-Wei Wang, Li-Yong Huang, Cheng-Li Song, Chang-Hua Zhuo, De-Bing Shi, Guo-Xiang Cai, Ye Xu, San-Jun Cai, Xin-Xiang Li. Laparoscopic <italic>vs</italic> open abdominoperineal resection in the multimodality management of low rectal cancersWorld Journal of Gastroenterology 2015; 21(35): 10174-10183 doi: 10.3748/wjg.v21.i35.10174
2
Hideomi Yamashita, Soichiro Ishihara, Hiroaki Nozawa, Kazushige Kawai, Tomomichi Kiyomatsu, Kae Okuma, Osamu Abe, Toshiaki Watanabe, Keiichi Nakagawa. Comparison of volumetric-modulated arc therapy using simultaneous integrated boosts (SIB-VMAT) of 45 Gy/55 Gy in 25 fractions with conventional radiotherapy in preoperative chemoradiation for rectal cancers: a propensity score case-matched analysisRadiation Oncology 2017; 12(1) doi: 10.1186/s13014-017-0894-9
3
Gabriella Buccafusca, Ilaria Proserpio, Antonino Carmelo Tralongo, Sebastiano Rametta Giuliano, Paolo Tralongo. Early colorectal cancer: diagnosis, treatment and survivorship careCritical Reviews in Oncology/Hematology 2019; 136: 20 doi: 10.1016/j.critrevonc.2019.01.023
4
Gloria O'Connor, Vivien Coates, Siobhan O'Neill. Exploring the information needs of patients with cancer of the rectumEuropean Journal of Oncology Nursing 2010; 14(4): 271 doi: 10.1016/j.ejon.2010.01.024
5
D. V. Sidorov, B. Ya. Alekseev, M. V. Lozhkin, N. V. Vorobyev, L. O. Petrov, N. A. Grishin, A. A. Troitsky, P. A. Korolev, R. I. Moshurov. 100 small pelvic exenterations in patients with locally advanced primary and recurrent rectal tumorsOnkologiya. Zhurnal imeni P.A.Gertsena 2017; 6(2): 5 doi: 10.17116/onkolog2017625-11
6
Joanne Favuzza, Conor Delaney. Principles of Flexible Endoscopy for Surgeons2013; : 191 doi: 10.1007/978-1-4614-6330-6_17
7
Pedro Campelo, Elisabete Barbosa. Functional outcome and quality of life following treatment for rectal cancerJournal of Coloproctology 2016; 36(4): 251 doi: 10.1016/j.jcol.2016.05.001
8
A. P. Kolesnik, I. P. Kolesnik, V. V. Kechedzhyiev. Modern approaches to the diagnosis and surgical treatment of rectal cancer (Review of clinical recommendations)Modern medical technologies 2019; 40(1): 75 doi: 10.34287/MMT.1(40).2019.12
9
M.A. Lucic, I.S. Miucin-Vukadinovic, S.M. Lucic, K.M. Koprivek, M. Spirovski, D. Kozarski, Dj. Saranovic. Newer techniques in diagnostic imaging of colorectal carcinomaActa chirurgica iugoslavica 2009; 56(4): 113 doi: 10.2298/ACI0904113L
10
Grace G. Wong, Vincent Ha, Michael P. Chu, Deonne Dersch-Mills, Sunita Ghosh, Carole R. Chambers, Michael B. Sawyer. Effects of Proton Pump Inhibitors on FOLFOX and CapeOx Regimens in Colorectal CancerClinical Colorectal Cancer 2019; 18(1): 72 doi: 10.1016/j.clcc.2018.11.001
11
Gloria O'Connor. Review: Challenges in recruiting participants in a multi-centre study on symptom experiences and self care strategies of bowel symptoms following colo-rectal surgeryJournal of Research in Nursing 2012; 17(5): 507 doi: 10.1177/1744987111423190
12
Erica Amaral, Maria Bernardes, Sara Ribeiro, Beatriz Rosa, Ana Pereira, Sandra F. Martins. Predictors of pathological response and clinical outcome following chemoradiation for locally advanced rectal cancer – a systematic reviewJournal of Coloproctology 2020;  doi: 10.1016/j.jcol.2020.05.005
13
Chang-Zheng Du, Wei-Cheng Xue, Yong Cai, Ming Li, Jin Gu. Lymphovascular invasion in rectal cancer following neoadjuvant radiotherapy: A retrospective cohort studyWorld Journal of Gastroenterology 2009; 15(30): 3793-3798 doi: 10.3748/wjg.15.3793
14
Gloria O’Connor, Vivien Coates, Siobhan O’Neill. Randomised controlled trial of a tailored information pack for patients undergoing surgery and treatment for rectal cancerEuropean Journal of Oncology Nursing 2014; 18(2): 183 doi: 10.1016/j.ejon.2013.10.011
15
Ionut Cristian Radu, Ariana Hudita, Catalin Zaharia, Bianca Galateanu, Horia Iovu, Eugenia (Vasile) Tanasa, Sabina Georgiana Nitu, Octav Ginghina, Carolina Negrei, Aristidis Tsatsakis, Kelly Velonia, Mikhail Shtilman, Marieta Costache. Poly(3-hydroxybutyrate-CO-3-hydroxyvalerate) PHBHV biocompatible nanocarriers for 5-FU delivery targeting colorectal cancerDrug Delivery 2019; 26(1): 318 doi: 10.1080/10717544.2019.1582729